Tuesday 8 April 2014

[6649MSCRMCV] Urgent Need : Oracle Clinical Developer in NJ [US Citizen|GC|EAD Only]-sandeep@clearthoughtsolutions.com

US Citizen|GC|EAD Only

Title : Oracle Clinical Developer

Duration :long term contract

Location : Princeton/Berkeley Heights NJ.

 

The CRF’s are developed Clintrial.

The specs were sent to the CRO’s who build their own database using OCR.

The data would come back to for testing and this would be is SAS format.

 

·         Develop the eCRF layout and the database corresponding to the eCRFs to hold the data from the EDC system.

·         Review and provide input to Clinical team on specific sections of clinical trial protocol and data handling guidelines.

·         Program and test the data validation specifications (Edit checks) to ensure if edit checks are failing as intended.

·         Create the standard eCRF and maintain global library.

 

·         Create the data extract specifications for any data transformation from EDC to Clintrial.

·         Provide the data transfer specifications, test transfers and load third party data.

·         Develop database specifications and ensure the database design is with the standards.

·         Develop and study specific reports.

·         Program basic SQL queries to resolve problems with the eCRF applications.

·         Support reporting requirements using SQL and SAS.

·         Create and file trial documentation


-- 

Thank you

Sandeep R Tummuru || Resource Manager

Clear Thought Solutions LLC.,

Ph: 919 290 4346

Email : sandeep@clearthoughtsolutions.com,

gtalk : sandy4cts

Website : www.clearthoughtsolutions.com

--
You received this message because you are subscribed to the Google Groups "CVMSCRM" group.
To unsubscribe from this group and stop receiving emails from it, send an email to cvmscrm+unsubscribe@googlegroups.com.
To post to this group, send email to cvmscrm@googlegroups.com.
Visit this group at http://groups.google.com/group/cvmscrm.
For more options, visit https://groups.google.com/d/optout.

No comments:

Post a Comment